International Biotechnology Trust PLC

International Biotechnology (LON:IBT) shares have crossed above their 200-day moving average, trading at GBX 962, up 0.6%. The stock reached a high of GBX 974, with a market cap of £306.91 million and a price-to-earnings ratio of -292.40. The company aims for long-term capital growth by investing in biotechnology and life sciences. Analysts currently rate the stock as a Hold, suggesting that there are better investment options available.

Market Beat

International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average   - Here's Why

International Biotechnology Trust PLC has announced its unaudited net asset values (NAV) per share as of January 26, 2026. The NAV Ex Income is 1027.20 pence, while the NAV Cum Income is 995.02 pence. These values were calculated following the guidelines of the Association of Investment Companies. For further inquiries, contact Schroder Investment Management Limited.

London Stock Exchange

REG - Intnl. Biotechnology - Net Asset Value(s)

International Biotechnology (LON:IBT) stock has surpassed its 200-day moving average, trading at GBX 982, up 0.4%. The stock's 200-day average is GBX 803.83, with a market cap of £314.64 million and a P/E ratio of -299.77. The company reported an EPS of GBX (11.42) for the last quarter and has a return on equity of 13.67%. Analysts forecast an EPS of 0.94 for the current fiscal year. Despite the stock's performance, it currently holds a Hold rating among analysts, who suggest other stocks may be better investments.

International Biotechnology Trust PLC(IBT.UK)

International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average - Here's Why

REG - Intnl. Biotechnology - Net Asset Value(s)

International Biotechnology (LON:IBT) Stock Price Passes Above 200 Day Moving Average - Here's Why